(Press-News.org) COLUMBUS, Ohio – Using a prebiotic to influence bacterial activity in the gut after a traumatic brain injury may help reduce impulsive behavior, one of the common symptoms to follow a moderate blow to the head, a new study in rats suggests.
Following up on previous work showing a connection between negative changes to gut bacteria after a traumatic brain injury (TBI) and poor decision making, researchers at The Ohio State University are now exploring whether the gut problems may actually cause some long-term symptoms.
They found that adding the prebiotic galacto-oligosaccharide (GOS) to rat diets before and after a TBI lowered their impulsivity in a decision-making gambling test in which they are rewarded with sweets.
“We found in this study that their impulse control has improved,” said senior author Cole Vonder Haar, assistant professor of neuroscience in the Ohio State College of Medicine.
“In our task, we basically ask them to make a decision, but they have to wait for the cue light to come on. And that’s hard to do if you’re a hungry rat, right? So it sets up a measure of impulsivity, and that’s where we saw one of the most robust effects.”
The poster was presented Nov. 17 at Neuroscience 2025, the annual meeting of the Society for Neuroscience.
Almost 3 million TBI-related emergency department visits are reported in the United States each year, and over 11 million Americans over 40 who lost consciousness with a TBI are living with a disability, according to the Brain Injury Association of America.
“There’s no FDA-approved treatment for TBI. People are stuck with their symptoms and do whatever they can to manage those symptoms, whether it’s rehabilitation or pharmacological help for specific symptoms like depression,” Vonder Haar said.
His lab is studying several interventions to see if a gut-based treatment could provide some relief. “We’re trying to improve the quality of life for people who are suffering and struggling with brain injury-related problems,” he said.
The work focuses on symptoms that follow a moderate TBI – an injury in rats (occurring under anesthesia) intended to mimic what might happen to a person in a car accident or a fall from a ladder.
Within the past decade, researchers in the field have determined that gut dysbiosis – a negative change to the collection of bacteria in the digestive tract – occurs in patients after they suffer a moderate brain injury.
“The core question we’re trying to understand now is whether this is a causal force,” Vonder Haar said. “We’ve previously published data showing that there’s a very strong predictive correlation: If you measure the gut microbiome acutely after the brain injury, it can predict very long-term deficits in decision making. So it seems something is going on, but this earlier work was all correlative.”
In the new study, rats were fed a control diet or a diet supplemented with 2% GOS beginning six weeks before the injury and continuing for another 60 days after injury. The animals were then tested for anxiety-like and depressive-like behavior, learning and memory, and impulsivity and decision making.
During the rodent gambling task, which assesses decision making and impulsivity, rats are offered four choices resulting in rewards of varying amounts of sugar pellets, and they learn over time what each option provides.
“And one of the key things we see is that brain injuries really suppress the ability to do this well,” Vonder Haar said. “Our rat models really show this long-term chronic impairment, which patients also struggle with.”
Rats on the GOS diet had better outcomes in impulsivity after TBI than injured rats that ate a non-supplemented diet.
“It’s a modest effect. They’re still more impulsive than control animals without injury, but it’s reduced compared to their counterparts,” Vonder Haar said. “Most of the studies we’ve done to try to treat impulsivity haven’t worked out. This is one of the few times where it looks like a treatment has some beneficial effects.”
Vonder Haar also chaired a Nov. 16 Neuroscience 2025 minisymposium on the gut microbiome in traumatic brain injury and is the lead author of a new Journal of Neuroscience article reviewing the evidence establishing the gut as a modulator of TBI and potential underlying mechanisms.
“We know what the behavioral outcome from TBI looks like, but the mechanism, why and how this is happening, is the other big question,” he said.
The prebiotic study was supported by the U.S. Department of Defense.
Co-authors of the study include Alexandra Dorinsky, Katie Koontz, Berkin Bilgin, Lizza O’Connell, Jenna McCloskey, Michael Bailey and Kris Martens, all of Ohio State, and Miranda Hilt of Nationwide Children’s Hospital.
#
Contact: Cole Vonder Haar, Cole.Vonderhaar@osumc.edu
Written by Emily Caldwell, Caldwell.151@osu.edu; 614-292-8152
END
About The Study: In a cohort composed primarily of women with obesity, glucagon-like peptide-1 receptor agonist (GLP-1RA) use with subsequent pre-pregnancy or early pregnancy discontinuation was associated with more gestational weight gain and a higher risk of preterm delivery, gestational diabetes, and hypertensive disorders of pregnancy.
Corresponding Authors: To contact the corresponding authors, email Jacqueline Maya, MD, (jmaya@mgh.harvard.edu) and Camille E. Powe, MD, (camille.powe@mgh.harvard.edu).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.20951)
Editor’s Note: Please ...
About The Study: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are increasingly used for postpartum weight loss since the introduction of semaglutide for weight loss in late 2022. Most users were overweight prior to pregnancy and only 23% had a documented diabetes diagnosis, suggesting that the primary indication for use was weight reduction.
Corresponding Author: To contact the corresponding author, Mette Bliddal, PhD, email mbliddal@health.sdu.dk.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.20947)
Editor’s Note: Please see the article for additional information, including ...
In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders during pregnancy, and experienced preterm delivery more so than people who had never taken GLP-1 drugs. The findings are published in JAMA.
“The use of glucagon-like peptide-1 receptor agonists—or GLP-1RAs—has increased dramatically, but recommendations suggest their discontinuation before pregnancy ...
New research reveals that people with untreated obstructive sleep apnea have a higher risk of developing Parkinson’s disease. However, they can significantly reduce the risk by improving the quality of their sleep by using continuous positive airway pressure, or CPAP.
The study, which published today in the journal JAMA Neurology, examined electronic health records covering more than 11 million U.S. military veterans who received care through the Department of Veterans Affairs between 1999 and 2022.
The research was led by Oregon Health & Science University ...
About The Study: This cohort study found that the prevalence of avoidant/restrictive food intake in the general pediatric population was substantial, and affected children had an associated elevated risk of developmental difficulties across multiple domains. The findings suggest a need for broad support interventions and advance understanding of the genetic underpinnings of avoidant/restrictive food intake.
Corresponding Author: To contact the corresponding author, Ludvig Daae Bjorndal, PhD, email l.d.bjorndal@psykologi.uio.no.
To ...
About The Study: In this post hoc analysis of the SURMOUNT-4 trial, among participants with obesity who achieved weight reduction with 36-week tirzepatide (a glucagon-like peptide-1 receptor agonist) treatment, withdrawing tirzepatide led to 25% or greater weight regain in most participants within 1 year and was associated with a greater reversal of their initial cardiometabolic parameter improvements compared with those who maintained weight reduction. These findings underscore the importance of continued obesity treatment.
Corresponding Author: To contact the corresponding author, Clare J. Lee, MD, MHS, ...
About The Study: This cross-sectional study of the Global Burden of Disease 2021 study data found that, among the U.S. population of 332.7 million, disorders affecting nervous system health impacted 180.3 million U.S. individuals and were the top cause of disability. Conditions with the greatest collective disability were stroke, Alzheimer disease and
other dementias, diabetic neuropathy, and migraine. The U.S. should prioritize efforts to combat these conditions with development and implementation of new and effective prevention strategies, therapeutics, and focused rehabilitation.
Corresponding ...
About The Study: In this cohort of young adults, reducing social media use for 1 week was associated with reductions in symptoms of depression, anxiety, and insomnia; however, the durability of these therapeutic outcomes and their associations with behavior warrant further study, particularly in more diverse populations.
Corresponding Author: To contact the corresponding author, John Torous, MD, MBI, email torous@bidmc.harvard.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.45245)
Editor’s Note: Please ...
EMBARGOED FOR RELEASE AT 11 A.M. ET, MONDAY, NOVEMBER 24, 2025
Highlights:
A new systematic analysis shows more than half the people living in the U.S., 54%, are affected by a neurological disease or disorder.
Disorders of the nervous system impacted more than 180 million of the nearly 333 million Americans in 2021 and were the top cause of health loss in the U.S.
The nervous system includes the brain, spinal cord and nerves.
The most prevalent conditions were tension-type headache affecting 122 million Americans, migraine affecting 58 million and diabetic neuropathy affecting 17 million.
The leading causes of health loss were stroke, Alzheimer’s disease and ...
LMU researchers uncover the mechanism by which ribosomes raise alarms in the cell.
Ribosomes, the protein factories of the cell, are essential for all living organisms. They bind to mRNA and move along the messenger molecule, reading the genetic code as they go. Using this information, they link amino acids to make proteins. But their function goes far beyond pure production: Ribosomes are also important sensors for cellular stress and initiate protective reactions when problems arise. An international team led by Professor Roland Beckmann from LMU’s Gene Center ...